These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9403087)
1. [Management of atherosclerosis--new findings for the practice]. Internist (Berl); 1995 Feb; 36(2 Suppl Atheroskle):1-4. PubMed ID: 9403087 [No Abstract] [Full Text] [Related]
2. [Pravastatin: pharmacological action, pleiotropic effects and efficacy in prevention of atherosclerosis]. Bubnova MG; Aronov DM Kardiologiia; 2002; 42(7):88-95. PubMed ID: 12494119 [TBL] [Abstract][Full Text] [Related]
3. [Interventions in Atherosclerosis, Issues and Benefits. Proceedings of a symposium of the 62nd Congress of the European Atherosclerosis Association. Jerusalem, 5-9 September 1993]. Fortschr Med Suppl; 1993; 153():1-8. PubMed ID: 7905851 [No Abstract] [Full Text] [Related]
4. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates. Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560 [TBL] [Abstract][Full Text] [Related]
5. No primary prevention by pravastatin. Meyer FP Am J Med; 1998 Feb; 104(2):212-3. PubMed ID: 9528746 [No Abstract] [Full Text] [Related]
6. Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia. Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R Eur Heart J; 2004 Apr; 25(8):671-9. PubMed ID: 15084372 [TBL] [Abstract][Full Text] [Related]
7. Statins: much more than just a lipid-lowering therapy. Raja SG; Dreyfus GD Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561 [No Abstract] [Full Text] [Related]
8. Decrease in all-cause and CHD mortality with pravastatin over a broad range of initial cholesterol levels. Goodwin L J Insur Med; 1998; 30(4):276-7. PubMed ID: 10537938 [No Abstract] [Full Text] [Related]
9. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
10. Reversal of atherosclerosis with aggressive lipid lowering. Farmer JA Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721 [No Abstract] [Full Text] [Related]
11. [Endothelium, lipids and atherosclerosis]. Jorge PA Arq Bras Cardiol; 1997 Feb; 68(2):129-34. PubMed ID: 9433841 [No Abstract] [Full Text] [Related]
12. Economic benefit analysis of primary prevention with pravastatin. Assumptions are methodologically flawed. Freemantle N; Mason J BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9583930 [No Abstract] [Full Text] [Related]
13. Statins in acute coronary syndromes: from bench to bedside. Jackson G Int J Clin Pract; 2001 Sep; 55(7):427-8. PubMed ID: 11594247 [No Abstract] [Full Text] [Related]
15. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate. Pharoah P BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009 [No Abstract] [Full Text] [Related]